Revena secures $8M seed to automate Brazil hospital billing fast!

Revena, a São Paulo AI startup tackling hospital billing, has closed an oversubscribed $8 million seed round to scale its revenue-cycle automation across Brazil. The round was led by Canary with participation from Flourish Ventures. Investors cited clear unit economics and immediate hospital impact as the rationale for backing the company.

Brazil spends heavily on healthcare—around 10% of GDP—yet many private hospitals lose large portions of revenue to administrative gaps. Billing teams, nurses and auditors often spend the equivalent of nearly two full working days (about 18 hours per five-day hospitalization) on paperwork and re-keying data, and institutions can see up to 25% revenue leakage. These frictions create a ripe opportunity for automation that can read and reconcile clinical and payer data instead of simply digitizing forms.

The founding team—CEO Mateus Noronha and CTO Diogo Freitas—met at the Instituto Tecnológico de Aeronáutica and later cut their teeth at other Brazilian tech startups. Their complementary strengths—customer-facing operations and deep engineering—shaped a product designed for fast deployment and measurable ROI. Early pilots convinced hospital leaders: Revena’s system returned value during short trials and produced tangible recovery of missed billable items.

Revena embeds AI agents into hospitals’ existing information systems to extract clinical context, interpret complex insurer rules and generate compliant claims directly in Electronic Medical Records. A human-in-the-loop layer of trained nurses reviews edge cases and feeds corrections back into the models, tightening accuracy over time. The company reports implementation timelines of around two weeks, versus the typical six- to twelve-month rollouts associated with legacy enterprise software.

The startup’s live deployments demonstrate meaningful outcomes: deployments across more than 60 hospitals produced an estimated 6–18% uplift in recovered revenues, a 65–75% reduction in financial operations workload and roughly 23% faster submission of claims. Revena says it achieved rapid commercial traction—growing roughly 20x in the most recent reported year—by charging on a performance-linked model where hospitals pay based on verified revenue recovery.

With the new capital, Revena plans to broaden automation beyond insurer-reimbursed billing to include public-system (SUS) workflows, accounts payable, reconciliation and other adjacent financial operations. Management frames the ambition as building the financial infrastructure that underpins healthcare cash flows in Brazil—an ecosystem they estimate at about $190 billion annually—and moving hospitals from manual reconciliation toward automated settlement and working-capital products.

Investors see a combination of clinical complexity and persistent manual effort as an ideal target for modern AI. By focusing on measurable revenue recovery and operational relief, Revena is positioning itself as a fintech-like layer for hospitals’ receivables and payables. Backers led by Canary alongside Flourish Ventures are banking on that infrastructure play to deliver both improved margins for providers and system-level efficiencies for Brazilian healthcare.